Organization

ChromaDex Corporation

About

ChromaDex is a bioscience company dedicated to the support and development of healthy aging. The company has initiatives in research related to nicotinamide adenine dinucleotide (NAD+), which is found in every cell as we age. Being known for its active role in cellular energy production, NAD+ is now thought to hold an important role in healthy aging, as it is an essential coenzyme and key regulator of cellular metabolism and is required for efficient and proper mitochondrial function.

Overview

Founded 1999
Type Public
Location Los Angeles, California, USA

Stock

CDXC $1.25 -4.58% $(0.06)

Latest News

This Analyst Cuts ChromaDex's Price Target On Revised Growth Trajectory Aug 29, 2022 Benzinga Earlier this month, ChromaDex Corp (NASDAQ: CDXC) released Q2 earnings, indicating high single-digit revenue growth for FY22, driven by its global e-commerce business, offset by...
Benzinga's Top Ratings Upgrades, Downgrades For August 16, 2022 Aug 16, 2022 Benzinga Upgrades Craig-Hallum upgraded the previous rating for CalAmp Corp (NASDAQ:CAMP) from Hold to Buy. In the first quarter, CalAmp showed an EPS of $0.10, compared...
Why FlexShopper Surged Over 47%; Here Are 104 Biggest Movers From Yesterday Aug 12, 2022 Benzinga Gainers Digital Media Solutions, Inc. (NYSE: DMS) jumped 78.8% to close at $2.11. Digital Media Solutions recently reported worse-than-expected Q2 EPS and sales results. TOP...
Why Matterport Is Trading Higher By Around 25%, Here Are 73 Stocks Moving In Thursday's Mid-Day Session Aug 11, 2022 Benzinga Gainers Timber Pharmaceuticals, Inc. (NYSE: TMBR) shares rose 63.8% to $0.1769. Timber Pharmaceuticals recently announced closing of $8.0 million public offering. T2 Biosystems, Inc. (NASDAQ:...
Benzinga's Top Ratings Upgrades, Downgrades For August 11, 2022 Aug 11, 2022 Benzinga Upgrades Evercore ISI Group upgraded the previous rating for Deere & Co (NYSE:DE) from In-Line to Outperform. In the second quarter, Deere showed an EPS...